Our Mission Statement
This is Photoshop's version of Loremer Ipsn gravida nibh vel velit auctoregorie sam alquet.Aenean sollicitudin, lorem quis bibendum auci elit consequat ipsutis sem nibh id elit.
Follow Us
Publications – Transcell
page-template-default,page,page-id-7077,mkd-core-1.0,highrise-ver-1.0,,mkd-smooth-page-transitions,mkd-ajax,mkd-grid-1300,mkd-blog-installed,mkd-header-vertical,mkd-sticky-header-on-scroll-up,mkd-default-mobile-header,mkd-sticky-up-mobile-header,mkd-dropdown-slide-from-bottom,mkd-dark-header,mkd-full-width-wide-menu,mkd-search-dropdown,mkd-side-menu-slide-from-right,wpb-js-composer js-comp-ver-5.0.1,vc_responsive


  1. Elisa Fiorito, Yogita Sharma, Siv Gilfillan, Shixiong Wang, Alfonso Urbanucci, Madhumohan R. Katika , Ian G. Mills and Antoni Hurtado. CTCF controls ER-mediated transcription through specific chromatin interactions (2016). Nucleic acid Research.
  1. JF Swennenhuis, AGJ Tibbe, M Stevens, MR Katika, J van Dalum (2015). Self-seeding microwell chip for the isolation and characterization of single cells. Lab on a chip 15 (14), 3039-3046.
  1. Katika MR, Peter J.M. Hendriksen, Henk van Loveren, Ad Peijnenburg (2013). Characterization of the modes of action of deoxynivalenol (DON) in human T lymphocyte Jurkat cells. Journal of Immunotoxicology. 2014 Jul 2:1-1.
  1. Katika MR, Peter J.M. Hendriksen, Henk van Loveren, Ad Peijnenburg (2010). Exposure of Jurkat cells to bis(tri-n-butyltin) oxide (TBTO) induces transcriptomics changes indicative for ER- and oxidative stress, T cell activation and apoptosis. Toxicol and Appl Pharmacol, 254 (2011) 311–322.
  1. Katika MR, Peter J.M. Hendriksen, Henk van Loveren, Ad Peijnenburg (2011). Immunocytological and biochemical analysis of the mode of action of bis (tri-n-butyltin) tri-oxide (TBTO) in Jurkat cells. Toxicol Letters, 2012 Jul 20;212(2):126-36.
  1. Katika MR, Peter J.M. Hendriksen, Henk van Loveren, Ad Peijnenburg (2012). Transcriptome analysis of the human T lymphocyte cell line Jurkat and human peripheral blood mononuclear cells exposed to deoxynivalenol (DON): New mechanistic insights. Toxicol and Appl Pharmacol, 2012 Oct 1; 264(1):51-64.
  1. Katika MR*, Fiorito E, Hurtado A (2013). Cooperating transcription factors mediate the function of estrogen receptor. Chromosoma, 2013 Mar; 122(1-2): 1-12.
  1. Katika MR, Hurtado A (2013). A functional link between FOXA1 and breast cancer SNPs. Breast Cancer Res, 2013 Feb 18; 15(1): 303. (IF -5.49).
  2. Katika MR*, Shao J, Schmeits PC, Hendriksen PJ, van Loveren H, Peijnenburg AA, Volger OL (2013). Toxicogenomics-based identification of mechanisms for direct immunotoxicity. Toxicol Sciences, 2013 Jul 3.
  3. Katika MR*, Schmeits PC, van Loveren H, Peijnenburg AA, Hendriksen PJ (2013) Confirmation of the mechanisms of action of deoxynivalenol and tributyltin oxide with positive controls of ribotoxic stress and endoplasmic reticulum stress in Jurkat T cells. Toxicol Letters, 2013 Nov 15; S0378-4274(13)01396-9.
  1. Purushottam, Madhumohan, Mohammad Anwaruddin, H.A Nagarajaram, Vuppaladadhiam Hariram, Calambur Narasimhan, Murali D Bashyam (2010). The MYH7 p.R787H mutation causes hypertrophic cardiomyopathy in two unrealted families. Experimental clinical Cardiology, 2010;15(1).
  2. Bashyam MD, Purushotham G, Chaudhary AK, Madhumohan K, Acharya V, Mohammad TA, Nagarajaram HA, Hariram V, Narasimhan C (2012). A low prevalence of MYH7/MYBPC3 mutations among Familial Hypertrophic Cardiomyopathy patients in India. Mol Cell Biochem, 2012 ;360(1-2): 373-82.
  1. Katika MR, Peter J.M. Hendriksen, Henk van Loveren, Ad Peijnenburg (2009). Unraveling of the mode of action of immunotoxicity of TBTO using GSEA (2009). Toxicology letters, 189 (13).
  1. MR Katika, R Martin, S Gilfillan, A-L Børresen-Dale, S Lopez and A Hurtado. Selective inhibition of HER2 signaling pathway reveals novel functions of FOXA1 in breast cancer (2013). Molecular Cancer Therapeutics, 12; B124.
  1. MR Katika, S Gilfillan, S Nothagen, E Fiorito, B Bai, E Gonzalez, Y Sharma, A-L Børresen-Dale, S and A Hurtado. Selective stimulation of HER-2/HER-3 signaling-pathway triggers FOXA1 and confers hormone resistance in breast cancer. International journal of molecular medicine, 34, S110-S110.
  1. MR Katika*, PC Schmeits, A Peijnenburg, H van Loveren, PJM Hendriksen. Comparison of the effects of deoxynivalenol and tributylin oxide to that model compounds inducing endoplasmic reticulum stress, ribotoxic stress and T cell activation. The Toxicologist 132, 445-445.

Articles / Chapters published in books

  1. Elsevier, Toxicogenomics-Based Cellular Models: Alternatives to Animal Testing fo safety assessment, (ISBN 9780123978714).

Invited talks

  1. A toxicogenomics approach to study the mode of action of tributyltin oxide on human T lymphocytes. 6th Meeting of the Immunotoxicology & Chemical allergy specialty section (ITCASS) NOTOX den Bosch, The Netherlands.
  2. Unraveling of the mode of action of immunotoxicity of TBTO using GSEA. National research council Symposium of the standing committee on Risk analysis issues and reviews, National academy of sciences, Washington DC, USA. (Received a Travel grant award).
  3. Isolation and Characterization of Single Circulating Tumor Cells in a Self-Sorting Nanowell Plate. Oral talk presented 2nd International Symposium on Advances in Circulating Tumor Cells (ACTC 2014) Crete, Greece.
  4. Genetic testing and Genome medicine Industry prospective, Invitation for 3rd Indian Cancer Genetics Conference, ACTREC, Mumbai, India
  5. Tumor organoids for anti cancer drug screening. Dr.Reddys Institute of Life sciences (DRILS) Hyderabad, India.
  6. Advances in Next generation sequencing technologies. National seminar on frontiers in Microbial biotechnology, Osmania university Hyderabad, India.